NCT05571007

Brief Summary

OBJECTIVE: To investigate the effect of acupressure on fatigue in patients with end-stage renal disease (ESRD) undergoing hemodialysis (HD) as well as assess sleep quality and psychological status HYPOTHESIS TO BE TESTED: Upon intervention completion, the experimental group will exhibit lower severity of fatigue and depression/anxiety and improved sleep quality compared to the control group. DESIGN AND SUBJECTS: A randomized controlled trial with experimental and control groups. A total of 116 patients with ESRD who screen positive for fatigue severity ≥ 4 (using a single-item indicator of fatigue, which ranges from 0 to 10 points) will be recruited. STUDY INSTRUMENTS: Brief Fatigue Inventory (BFI), Pittsburgh Sleep Quality Index (PSQI), and Hospital Anxiety and Depression Scale (HADS) INTERVENTION: A 4-week acupressure intervention was performed by the principal investigator (PI) for every subject by applying the rate of two rotations per second, three times a week. MAIN OUTCOME MEASURES: Primary: fatigue. Secondary: sleep quality, depression, and anxiety. DATA ANALYSIS: Multiple regression was used to analyze between-group differences in BFI and PSQI, while ordinal logistic regression was used to analyze the subscales of the HADS. EXPECTED RESULTS: The proposed acupressure intervention is useful for alleviating fatigue and related symptoms (sleep quality, depression, and anxiety) experienced by patients with ESRD.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
116

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2019

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2019

Completed
2.8 years until next milestone

First Submitted

Initial submission to the registry

September 30, 2022

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 7, 2022

Completed
Last Updated

October 7, 2022

Status Verified

October 1, 2022

Enrollment Period

4 months

First QC Date

September 30, 2022

Last Update Submit

October 5, 2022

Conditions

Keywords

End-stage renal diseaseHemodialysisAcupressureFatigueSleepAnxiety/depression

Outcome Measures

Primary Outcomes (2)

  • Brief Fatigue Inventory (BFI)

    A questionnaire will be used to measure the severity of fatigue in the past 24 hours. This 9-item self-reported questionnaire is scored on a 0-10 numerical rating scale, where 0 and 10 represent absence and the highest severity of fatigue, respectively. The BFI score is classified into mild (1-3 points), moderate (4-6 points), and severe fatigue (7-10 points).

    Before the intervention (baseline, T0)

  • Brief Fatigue Inventory (BFI)

    A questionnaire will be used to measure the severity of fatigue in the past 24 hours. This 9-item self-reported questionnaire is scored on a 0-10 numerical rating scale, where 0 and 10 represent absence and the highest severity of fatigue, respectively. The BFI score is classified into mild (1-3 points), moderate (4-6 points), and severe fatigue (7-10 points).

    Completion of the 4-week intervention (post-test, T1)

Secondary Outcomes (4)

  • Pittsburgh Sleep Quality Index (PSQI)

    Before the intervention (baseline, T0)

  • Pittsburgh Sleep Quality Index (PSQI)

    Completion of the 4-week intervention (post-test, T1)

  • Hospital Anxiety and Depression Scale

    Before the intervention (baseline, T0)

  • Hospital Anxiety and Depression Scale

    Completion of the 4-week intervention (post-test, T1)

Study Arms (2)

True acupressure

EXPERIMENTAL

Using three true acupoints. Acupoints: Yongquan (K1), Sayingjiao (SP6), Zusanli (ST36). Patient Position: Lying or sitting position. Time: first 2 hours of HD.

Other: True acupressure

Sham acupressure

SHAM COMPARATOR

Using three sham acupoints. Acupoints: Sham acupoints are located on 1 cun from the true acupoint. Patient Position: Lying or sitting position. Time: first 2 hours of HD.

Other: Sham acupressure

Interventions

Duration: 3 minutes for each acupoint, applied bilaterally (right and left sides). Total time: 18 minutes/acupressure therapy.

True acupressure

Duration: 3 minutes for each acupoint, applied bilaterally (right and left sides). Total time: 18 minutes/acupressure therapy.

Sham acupressure

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \. Age ≧ 18 years
  • \. HD therapy for at least 3 months
  • \. Experience of fatigue (fatigue severity ≥ 4, using a single-item indicator of fatigue, ranging from 0 to 10 points)
  • \. Absence of lower limb wounds
  • \. Did not receive any complementary treatment

You may not qualify if:

  • \. Diagnosis of major depression or psychiatric disorders
  • \. Wound or amputation of the lower extremities, rheumatoid arthritis, or limb fracture

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

RS Prof Dr Margono Soekardjo Purwokerto

Purwokerto, Central Java, Indonesia

Location

Related Publications (1)

  • Suandika M, Chen SY, Fang JT, Yang SH, Tsai YF, Weng LC, Tsay PK, Tang WR. Effect of Acupressure on Fatigue in Hemodialysis Patients: A Single-Blinded Randomized Controlled Trial. J Integr Complement Med. 2023 Feb;29(2):111-118. doi: 10.1089/jicm.2022.0644. Epub 2022 Nov 22.

MeSH Terms

Conditions

Kidney Failure, ChronicFatigueAnxiety DisordersDepression

Condition Hierarchy (Ancestors)

Renal Insufficiency, ChronicRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsMental DisordersBehavioral SymptomsBehavior

Study Officials

  • Made Suandika, PhDCandidate

    School of Nursing, Harapan Bangsa University, Central Java, Indonesia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

September 30, 2022

First Posted

October 7, 2022

Study Start

July 1, 2019

Primary Completion

October 30, 2019

Study Completion

November 30, 2019

Last Updated

October 7, 2022

Record last verified: 2022-10

Locations